{
    "clinical_study": {
        "@rank": "62271", 
        "arm_group": [
            {
                "arm_group_label": "Usual care", 
                "arm_group_type": "No Intervention", 
                "description": "Usual care"
            }, 
            {
                "arm_group_label": "Exercise", 
                "arm_group_type": "Active Comparator", 
                "description": "exercise intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The proposed research aims to examine whether regular aerobic exercise can preserve renal\n      function, improve aerobic capacity, physical and psychosocial function, strength,\n      cardiovascular function, general well-being and quality of life. Ultimately, the research\n      aims to prove that exercise is a more cost-effective and a more efficient use or healthcare\n      resources used in the treatment of patients with CKD. Exercise is a relatively cheap\n      treatment option which is readily available and accessible for this patient population.\n      establish if, compared with usual care, an exercise programme for pre-dialysis CKD patients;\n\n        1. Preserves renal function.\n\n        2. Improves aerobic capacity, physical and psychosocial function, strength, cardiovascular\n           function, general well-being and quality of life."
        }, 
        "brief_title": "Effect of Exercise on Renal Function in Predialysis", 
        "completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Kidney Disease", 
        "condition_browse": {
            "mesh_term": [
                "Cardiovascular Diseases", 
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  - Stages 3-4 chronic kidney disease (CKD) patients (glomerular filtration rate (GFR)\n             20-60 mL/min)\n\n          -  Male or female\n\n          -  Aged >18 years\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n               -  Requiring support for ambulation less than 20m\n\n               -  Vasculitis,\n\n               -  Proliferative diabetic retinopathy,\n\n               -  Severe osteodystrophy,\n\n               -  Uncontrolled diabetes,\n\n               -  Psychiatric illness, including anxiety, mood and untreated eating disorders\n\n               -  Infection or course of antibiotics within the last month"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02155036", 
            "org_study_id": "KCH11-123"
        }, 
        "intervention": {
            "arm_group_label": "Exercise", 
            "description": "The intervention will include 2 sessions of gym-based exercise per week, both of which will be supervised for 3 months, supervision will then decrease to once-weekly until 6 months, and then be through phone support for the remaining 6 months.   Warm up and cool down of minimum of five minutes on stationary exercise cycle, rate of perceived exertion (RPE) ~11, followed by gentle stretching. Progressive resistance training (PRT) will use eight PRT machines training large muscle groups (e.g. bench press, latissimus pulldown, bicep curl, triceps pull down, leg press, knee extension, hamstring curl, calf raises).  Intensity will be 80% of one repetition maximum (1RM), building up to 3 sets of 8 repetitions.  1RM will be re-assessed monthly, and program adjusted accordingly.", 
            "intervention_name": "Exercise", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "exercise", 
            "rehabilitation", 
            "kidney function", 
            "cardiovascular disease risk"
        ], 
        "lastchanged_date": "June 3, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "United Kingdom", 
                    "zip": "SE5 9RS"
                }, 
                "name": "King's College Hospital"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Exercise on Renal Function and Cardiovascular Disease in Pre-dialysis (Chronic Kidney Disease Stage 3-4) Patients With Chronic Kidney Disease; a Randomised Controlled Trial Pilot Study.", 
        "overall_official": {
            "affiliation": "King's College Hospital NHS Trust", 
            "last_name": "sharlene greenwood, Bsc", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: The UK ethics committee authority", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "estimated glomerular filtration rate (egfr) creatinine", 
            "measure": "kidney function", 
            "safety_issue": "No", 
            "time_frame": "up to 12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02155036"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "cycle ergometer", 
                "measure": "Cardio-respiratory fitness testing (VO2peak)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months"
            }, 
            {
                "description": "Vicorder equipment, carotid-femoral region.", 
                "measure": "Pulse Wave Velocity (arterial stiffness)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months"
            }, 
            {
                "measure": "Body mass index (BMI)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months"
            }, 
            {
                "measure": "weight", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months"
            }, 
            {
                "measure": "Waist circumference", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months"
            }, 
            {
                "description": "questionnaire", 
                "measure": "Duke's activity status index", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months"
            }, 
            {
                "measure": "Short Form 36 questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months"
            }, 
            {
                "measure": "Total cholesterol", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months"
            }, 
            {
                "measure": "High sensitivity c-reactive protein (Hs CRP)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months"
            }, 
            {
                "measure": "Blood pressure", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months"
            }, 
            {
                "measure": "Resting heart rate (HR)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months"
            }, 
            {
                "measure": "Triglycerides", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 and 12 months"
            }
        ], 
        "source": "King's College Hospital NHS Trust", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "King's College Hospital NHS Trust", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}